National Nanotechnology Initiative: Charting the Course for Reauthorization
April 24, 2008
02:30 PM SR 253
02:30 PM SR 253
Nanotechnology has the potential to be the next great technological revolution. Currently, the federal investment, through the National Nanotechnology Initiative (NNI), is nearly $1.5 billion. This hearing will examine the five year period since the NNI was initially authorized in 2003 and explore issues the Committee should consider for the next reauthorization.
The webcast will be audio only.
If you are having trouble viewing this hearing, please try the following steps:
- Clear your browser's cache - Guide to clearing browser cache
- Close and re-open your browser
- If the above two steps do not help, please try another browser. Google Chrome and Microsoft Edge have the highest level of compatibility with our player.
Minority Statement
-
Ted Stevens
SenatorMinority Statement
Ted Stevens
Nanotechnology is a fascinating and revolutionary in many ways, and it has the potential to change and improve our lives.I think that we all think about it from the golf course to the emergency room, nanoscience is developing novel materials, devices, and systems that are opening up new avenues of science. Engineering controlling matter at sizes one one-thousandth the diameter of a human hair creates really an interest in the public and everyone concerned with it. I think that is such an amazing new area that is just plain fascinating to meAs nanotechnology evolves, safety becomes a topic of great interest. I think there appears to be very little evidence, so far, that nanotechnology is creating any serious dangers to our nation or is unsafe. On the contrary, I’m told medicine has made use of nanoparticles for at least 25 years without incident. Therapeutic medicines and magnetic resonance imaging tests already employ nanotechnology and have not revealed any demonstrably negative impacts on human health.In the absence of that I hope that Congress and the federal government will not as administrators or policy makers overestimate our role and we will conduct ourselves in a way to support the research and avoid imposing additional regulatory regimes on this developing field of science unless we are convinced additional regulation is warranted.
Testimony
-
The Honorable Richard M. Russell
Associate Director and Deputy Director for TechnologyExecutive Office of the PresidentDownload Testimony (505.50 KB) -
Mr. Robert A. Robinson
Managing Director, Natural Resources and Environment TeamU.S. Government Accountability OfficeDownload Testimony (384.61 KB)
Witness Panel 2
-
Mr. Matthew M. Nordan
PresidentLux Research IncorporatedDownload Testimony (188.36 KB) -
Mr. David Rejeski
Director, Foresight and Governance Project and Project on Emerging NanotechnologiesWoodrow Wilson CenterDownload Testimony (93.40 KB) -
Dr. P. Lee Ferguson
Assistant Professor, Department of Chemistry and BiochemistryUniversity of South CarolinaDownload Testimony (46.31 KB) -
Dr. Anita Goel MD, PhD
Chairman, CEO, and Scientific DirectorNanobiosym IncorporatedDownload Testimony (93.50 KB) -
Dr. Jim Heath
DirectorNSB Cancer CenterDownload Testimony (19.75 KB)